FindTrial
Sign In

The efficiency and safety of transperitoneal versus extraperitoneal robotic-assisted laparoscopic radical prostatectomy for patients with prostate cancer:a single-center, prospective, randomized controlled trial

The efficiency and safety of transperitoneal versus extraperitoneal robotic-assisted laparoscopic radical prostatectomy for patients with prostate cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011299
Enrollment
Unknown
Registered
2017-05-04
Start date
2017-05-08
Completion date
Unknown
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

1:transperitoneal robotic-assisted laparoscopic radical prostatectomy
2:extraperitoneal robotic-assisted laparoscopic radical prostatectomy

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. patients who have been diagnosed as prostate cancer; 2. patients who are voluntary to join in the trial.

Exclusion criteria

Exclusion criteria: 1. patients who have undergone other anti-tumor treatment; 2. patients who have other malignant tumors.

Design outcomes

Primary

MeasureTime frame
overall operation time;???????;robotic console time;postoperative hospitalization time;complications;time to first exsufflation;postoperative PSA level;postoperative continence;postoperative sexual function;—

Secondary

MeasureTime frame
drop of hemoglobin;—

Countries

China

Contacts

Public ContactLiu Zhenhua

West China Hospital, Sichuan University

machoa@163.com+86 18608033400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026